NIH Tetramer Core Facility

Opportunity Summary: NIH Tetramer Core Facility

Title: NIH Tetramer Core Facility
Issuing Organization: HEALTH AND HUMAN SERVICES, DEPARTMENT OF, NATIONAL INSTITUTES OF HEALTH, NATIONAL INSTITUTES OF HEALTH NIAID
Contact: Zachary Fetters
Email: [email protected]

Important Dates:

• Posted: January 22, 2026
• Due: February 6, 2026

Project Scope and Objectives:
The NIH Tetramer Core Facility represents a crucial initiative focusing on the development and provision of tetramer reagents essential for T cell analysis. The project aims to facilitate research by improving the understanding of immune responses, with a particular emphasis on applications in vaccine development and immunotherapy.

Contract Type: Not specified.
Estimated Value: Not mentioned.

Mandatory Requirements:

• Companies must possess relevant certifications and registrations to qualify for this opportunity (specific certifications not provided).
• Key technical capabilities must include expertise in biochemical and biophysical techniques specific to tetramer technology and applications.

Preferred Qualifications:

• Experience with large-scale production of peptide-MHC tetramers.
• Familiarity with flow cytometry and T cell immunology research.
• Proven track record of collaborations with federal agencies or similar entities may provide a competitive advantage.

Geographic Restrictions: None explicitly mentioned.

Deliverables and Performance Standards:
While specific deliverables are not detailed, expectations likely include timely delivery of reagents, adherence to quality standards, and consistent communication with NIH personnel.

Evaluation Criteria:
Proposals will be assessed based on compliance with mandatory qualifications, relevant experience in related projects, and ability to meet the technical capabilities required for effective tetramer production and application.

Proposal Evaluation:
Submissions will be evaluated for their alignment with the project goals, technical merit, and the capability to deliver required services effectively.

This opportunity provides a chance for qualified organizations with the requisite skills in tetramer technology and T cell research to partner with a leading health research facility in advancing immune response understanding.